New vaginal gel enters first human safety tests
NCT ID NCT07281404
First seen Jan 11, 2026 · Last updated May 18, 2026 · Updated 20 times
Summary
This early-phase study tests a new gel (YASO GEL) in 72 healthy adults to see if it is safe and how the body absorbs it. Participants will apply the gel and provide blood and vaginal fluid samples. The study also looks at whether sexual activity affects drug levels. This is a first step to gather information for future research, not a treatment study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY-PHASE SAFETY AND PK STUDY OF A VAGINAL GEL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UPMC Magee-Womens Hospital
Pittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.